These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15780071)

  • 41. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
    Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
    Sheng G; Bernabe KQ; Guo J; Warner BW
    Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
    Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T
    Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gradual upregulation of OCI-5 expression during occurrence and progression of rat hepatocellular carcinoma.
    Jiang WJ; Man XB; Tang L; Song HY; Li SJ; Cai GJ; Qiu XH; Hu HP
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):257-61. PubMed ID: 16698587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
    Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
    Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):271-8. PubMed ID: 7827802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
    Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
    Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J; Zheng J; Fang W; Wu B
    Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line.
    Song L; Shen B; Li Y
    Chin Med J (Engl); 2001 Sep; 114(9):954-7. PubMed ID: 11780390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
    Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
    Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
    Streetz KL; Tacke F; Leifeld L; Wüstefeld T; Graw A; Klein C; Kamino K; Spengler U; Kreipe H; Kubicka S; Müller W; Manns MP; Trautwein C
    Hepatology; 2003 Jul; 38(1):218-29. PubMed ID: 12830005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway.
    Lee TK; Man K; Ling MT; Wang XH; Wong YC; Lo CM; Poon RT; Ng IO; Fan ST
    Carcinogenesis; 2003 Nov; 24(11):1729-36. PubMed ID: 12949053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.